Sipai Health Technology Co (HKSE:00314) Margin of Safety % (DCF Dividends Based): N/A (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00314 Sipai Health Technology Co Ltd HKSE:00314
64 GF Score
Price HK$1.50
GF Value HK$2.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Sipai Health Technology Co Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Sipai Health Technology Co's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

HKSE:00314 vs MCK, COR, CAH: Margin of Safety % (DCF Dividends Based) Comparison

For the Medical Distribution subindustry, Sipai Health Technology Co's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sipai Health Technology Co Margin of Safety % (DCF Dividends Based) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's Margin of Safety % (DCF Dividends Based) falls into.


HKSE:00314
64GF Score
Sipai Health Technology Co Ltd HKSE:00314
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sipai Health Technology Co (HKSE:00314) Overvalued in 2026?

Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued. The current stock price of HK$1.50 is trading 37.4% below its estimated GF Value™ of HK$2.39. GuruFocus considers Sipai Health Technology Co to be Possible Value Trap.

Key valuation signals for HKSE:00314:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: HK$2.39 vs. price of HK$1.50 (37.4% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the HKSE:00314 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sipai Health Technology Co Business Description

Other Exchanges AX1:Germany
Address 128 Tianmu West Road, 1603-1605A, 16th Floor, Tower 1, Kerry Enterprise Center, Jing\'an District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
64GF Score

Get the complete analysis for HKSE:00314

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.50
Price
HK$2.39
GF Value